These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 34494255)
21. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options. Worswick S; Cotliar J Dermatol Ther; 2011; 24(2):207-18. PubMed ID: 21410610 [TBL] [Abstract][Full Text] [Related]
22. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis. Ririe MR; Blaylock RC; Morris SE; Jung JY J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282 [TBL] [Abstract][Full Text] [Related]
23. Burn unit care of Stevens Johnson syndrome/toxic epidermal necrolysis: A survey. Le HG; Saeed H; Mantagos IS; Mitchell CM; Goverman J; Chodosh J Burns; 2016 Jun; 42(4):830-5. PubMed ID: 26810444 [TBL] [Abstract][Full Text] [Related]
24. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Schneider JA; Cohen PR Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852 [TBL] [Abstract][Full Text] [Related]
25. Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis. Chen CB; Hsu TH; Chung-Yee Hui R; Lu CW; Chen WT; Chiang PH; Wang CW; Chuang SS; Yang JY; Yang SY; Chang SY; Hsiao YC; Kao KC; Hu HC; Wu TS; Hsu CW; Hui-Kang Ma D; Chen SY; Tian YC; Cheng CY; Chen CH; Chi MH; Wu MY; Liu RF; Wang CH; Chang YC; Lin JY; Ho HC; Yu-Wei Lin Y; Chang CJ; Lin YJ; Ku CL; Hung SI; Chung WH; J Am Acad Dermatol; 2021 Jun; 84(6):1782-1791. PubMed ID: 32828861 [TBL] [Abstract][Full Text] [Related]
26. Ventilatory support in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. Phan K; Oh LJ; Issler-Fisher A; Rao A; Wong EH; Maitz P J Dermatolog Treat; 2022 Feb; 33(1):525-530. PubMed ID: 32412819 [TBL] [Abstract][Full Text] [Related]
27. Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis. Wong KC; Kennedy PJ; Lee S Australas J Dermatol; 1999 Aug; 40(3):131-4. PubMed ID: 10439522 [TBL] [Abstract][Full Text] [Related]
28. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review. Weinkle A; Pettit C; Jani A; Keller J; Lu Y; Malachowski S; Trinidad JC; Kaffenberger BH; Ergen EN; Hughey LC; Smith D; Seminario-Vidal L J Am Acad Dermatol; 2019 Sep; 81(3):749-757. PubMed ID: 31150704 [TBL] [Abstract][Full Text] [Related]
30. A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis. Antoon JW; Goldman JL; Shah SS; Lee B J Allergy Clin Immunol Pract; 2019 Jan; 7(1):244-250.e1. PubMed ID: 29859332 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study. Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410 [TBL] [Abstract][Full Text] [Related]
32. Differences in Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at Burn Centers and Nonburn Centers. Nygaard RM; Endorf FW J Burn Care Res; 2020 Sep; 41(5):945-950. PubMed ID: 32498082 [TBL] [Abstract][Full Text] [Related]
33. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study. Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132 [TBL] [Abstract][Full Text] [Related]
34. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center. Gleghorn KL; Voigt C; Kelly B Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145 [TBL] [Abstract][Full Text] [Related]
35. Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management. Mockenhaupt M Semin Cutan Med Surg; 2014 Mar; 33(1):10-6. PubMed ID: 25037254 [TBL] [Abstract][Full Text] [Related]
36. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China. Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979 [TBL] [Abstract][Full Text] [Related]
37. The ophthalmologist's role in the management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis. Fu Y; Gregory DG; Sippel KC; Bouchard CS; Tseng SC Ocul Surf; 2010 Oct; 8(4):193-203. PubMed ID: 20964982 [TBL] [Abstract][Full Text] [Related]
38. Complications of Stevens-Johnson syndrome beyond the eye and skin. Saeed H; Mantagos IS; Chodosh J Burns; 2016 Feb; 42(1):20-27. PubMed ID: 25865527 [TBL] [Abstract][Full Text] [Related]
39. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome. Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120 [TBL] [Abstract][Full Text] [Related]
40. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome). Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]